ArticleIntestinal research2022

Long-term efficacy and tolerability of dose-adjusted thiopurine treatment in maintaining remission in inflammatory bowel disease patients with NUDT15 heterozygosity.

Takato Maeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.